My watch list
my.bionity.com  
Login  
NEWS
Current news

Genzyme Receives Innovation Award from the National Organization for Rare Disorders (NORD) for the Development of Cerdelga®

Genzyme, a Sanofi company, announced that it has received the 2015 Industry Innovation Award from the National Organization for Rare Disorders (NORD) in recognition of Cerdelga® (eliglustat) capsules. Genzyme was selected for the company’s work in bringing an additional treatment option to ... more

Bluebee raises €1.75 million to bring supercomputing to genomics

Bluebee announced a pre-equity round of 1.75 million EUR (1.90 million USD) from investment firm Buysse & Partners and existing shareholder Delft University of Technology to bring its cloud-based, accelerated genomics solution to clinicians and labs. Bluebee’s technology, based on hybrid-co ... more

VTU Technology and Biomay Have Signed License Agreement

VTU Technology and Biomay, two Austrian biotech companies, announced, that they have entered into a licensing agreement for the production of recombinant allergens. VTU Technology grants Biomay access to VTU´s Pichia pastoris protein expression technology. Biomay will apply industrial Pichi ... more

UAlberta creates DNA bank to unlock genetic clues about stuttering

Scientists at the University of Alberta's Institute for Stuttering Treatment and Research (ISTAR) want Albertans to give a spit - five millilitres to be precise - to help find the cause and a cure for stuttering.Scientists at the University of Alberta's Institute for Stuttering Treatment an ... more

analytica China 2016 increases exhibition area by over 16 percent

analytica China will again open from October 10 to 12, 2016 at the Shanghai New International Expo Center (SNIEC). The exhibition is expected to take over 35,000 square meters (2014: 30,000), what makes it the largest analytica China ever. Exhibitors can benefit from preferential terms incl ... more

Dr. Holger Zinke presented with the Greifswald Research Award 2015

Dr. Holger Zinke is the first entrepreneur to be given the Greifswald Senior Research Award. The founder of BRAIN AG and winner of the German Environmental Prize was honoured by the jury of Greifswald University Club (GUC) for his achievements in the field of biotechnological research and d ... more

Novel insights in MET-proto-oncogene might lead to optimizing cancer treatment

The MET-proto-oncogene is involved in the pathogenesis of several tumors and therefore represents an interesting target for future therapies currently tested in dozens of clinical trials. Veronica Finisguerra, Andrea Casazza, Max Mazzone and colleagues from VIB, KU Leuven and UZ Leuven now ... more

Intercept Pharmaceuticals Announces Pivotal Phase 3 Clinical Trial of Obeticholic Acid in NASH

Intercept Pharmaceuticals, Inc. announced its plans for an international Phase 3 trial of obeticholic acid (OCA), the company's lead FXR agonist, in patients with non-cirrhotic nonalcoholic steatohepatitis (NASH) with liver fibrosis. OCA has received breakthrough therapy designation in this ... more

Medicago to build $245M production facility in Quebec City

Medicago announced that Quebec City will be home to its new production complex. The $245 million project will create 200 new high-skilled jobs by 2019, adding to the team of 180 employees already working at Medicago's Quebec City office and laboratories. The project is expected to generate ... more

Baxter BioScience to Expand Global Oncology Footprint with Acquisition of Oncaspa Portfolio for Leukemia

Baxter International Inc. announced it has signed a definitive agreement to acquire the Oncaspar® (pegaspargase) product portfolio from Sigma-Tau Finanziaria S.p.A. The acquisition further accelerates the innovation capabilities and the commercial presence of Baxter BioScience in growing on ... more

All news

New test could identify resistant tuberculosis faster

The time needed to genetically sequence the bacteria causing tuberculosis (Mtb) from patient samples has been reduced from weeks to days using a new technique developed by a UCL-led team. This could help health service providers to better treat disease, control transmission of this infectio ... more

PhoreMost Awarded £1.4M Innovate UK Funding to Develop Lead Oncology Programme

PhoreMost Ltd announced that it has been selected to receive a funding award of £1.4M (approximately $2.14M USD) from the UK’s innovation agency, Innovate UK, to develop its lead oncology programme targeting mutant KRAS cancers.Based on PhoreMost’s proprietary Protein Interference technolog ... more

NetScientific appoints Dr François R. Martelet as Chief Executive Officer

NetScientific announces the appointment of Dr François R. Martelet as Chief Executive Officer and Board Director.Dr Martelet will join the Group on 8 June 2015. Sir Richard Sykes, who has been Executive Chairman prior to this appointment, will revert to his position as Non-Executive Chairma ... more

Sights set on innovation: New approaches to vision with microchips holds out prospects for the blind

To date, chip-based retinal implants have only permitted a rudimentary restoration of vision. However, modifying the electrical signals emitted by the implants could change that. This is the conclusion of the initial published findings of a project sponsored by the Austrian Science Fund FWF ... more

Protein aggregates save cells during aging

Aging is a complex biological process which is accompanied by an increasing number of toxic protein aggregates in the cells. Scientists consider them the cause of various neurodegenerative disorders, such as Alzheimer's, Huntington's and Parkinson's disease. However, their exact role remain ... more

Small signaling molecule gives green light for cell division

Generating offspring is the evolutionary goal of all living organisms. The multiplication of individual cells is coordinated by the cell cycle. For the discovery of how this process is regulated in eukaryotes the Noble Prize was awarded in 2001. The team of Prof. Urs Jenal at the Biozentrum ... more

Themis Bioscience’s Raises up to EUR 10 Million in Series B

Themis Bioscience announced the first closing of EUR 7 Million in a Series B financing of up to EUR 10 Million, led by new investor Wellington Partners. Existing investors Ventech and Omnes Capital (formerly Crédit Agricole Private Equity) also participated in the round. Dr Regina Hodits, G ... more

QIAGEN partners with sequencing provider

QIAGEN N.V. announced that it has expanded its relationship with BG to provide QIAGEN’s Ingenuity® Variant Analysis™ in integrated bioinformatics for all customers of BGI’s sequencing services. Under the reseller agreement, BGI customers will receive sequencing data generated from their sam ... more

Decoding DNA's phonebook

New clues about diseases like inflammatory bowel disorder may be found thanks to a new genomic interactions catalogue by a group of researchers in Japan and the United Kingdom. This research is published in Nature Genetics.Biologists have compiled the most comprehensive catalogue of promote ... more

BIOCITECH: Over 20% increase in revenue for the residents in 2014

Biocitech announced the 2014 results achieved by its residents. Biocitech residents submitted encouraging results for 2014, with growth in many areas. The overall revenue for the complex’s residents grew by 21%, from €51.3 million ($55.5 million) in 2013 to €62 million ($67 million) in 2014 ... more

All news on bioanalytics

Bluebee raises €1.75 million to bring supercomputing to genomics

Bluebee announced a pre-equity round of 1.75 million EUR (1.90 million USD) from investment firm Buysse & Partners and existing shareholder Delft University of Technology to bring its cloud-based, accelerated genomics solution to clinicians and labs. Bluebee’s technology, based on hybrid-co ... more

VTU Technology and Biomay Have Signed License Agreement

VTU Technology and Biomay, two Austrian biotech companies, announced, that they have entered into a licensing agreement for the production of recombinant allergens. VTU Technology grants Biomay access to VTU´s Pichia pastoris protein expression technology. Biomay will apply industrial Pichi ... more

UAlberta creates DNA bank to unlock genetic clues about stuttering

Scientists at the University of Alberta's Institute for Stuttering Treatment and Research (ISTAR) want Albertans to give a spit - five millilitres to be precise - to help find the cause and a cure for stuttering.Scientists at the University of Alberta's Institute for Stuttering Treatment an ... more

Novel insights in MET-proto-oncogene might lead to optimizing cancer treatment

The MET-proto-oncogene is involved in the pathogenesis of several tumors and therefore represents an interesting target for future therapies currently tested in dozens of clinical trials. Veronica Finisguerra, Andrea Casazza, Max Mazzone and colleagues from VIB, KU Leuven and UZ Leuven now ... more

Medicago to build $245M production facility in Quebec City

Medicago announced that Quebec City will be home to its new production complex. The $245 million project will create 200 new high-skilled jobs by 2019, adding to the team of 180 employees already working at Medicago's Quebec City office and laboratories. The project is expected to generate ... more

arGEN-X awarded €1.5 million IWT grant to advance the application of NHance Fc modifications in therapeutic antibodies

arGEN-X N.V. announced that it has received a € 1.5 million grant from the Institute for the Promotion of Innovation by Sciences and Technology in Flanders (IWT). This grant will be used to advance and commercialize the application of the NHance® Fc modifications in therapeutic antibodies.  ... more

IMGM attains certificate of GLP compliance

IMGM Laboratories GmbH recently announced that it has attained the certificate of Good Laboratory Practice (GLP) compliance issued by the Bavarian Health and Food Safety Authority."GLP perfectly complements IMGM’s ISO 17025 accreditation and GCP QM system" says Michael Haberl, IMGM’s Head o ... more

Pieris Pharmaceuticals Appoints Jean-Pierre Bizzari, M.D., to its Board of Directors

Pieris Pharmaceuticals, Inc. announced that Jean-Pierre Bizzari, M.D. has joined the Company's Board bringing the total number of directors to six. Dr. Bizzari was the Executive Vice President, Group Head, Clinical Oncology Development at Celgene Corporation. Since joining Celgene in 2008, ... more

Fusion protein controls design of photosynthesis platform

Chloroplasts are the solar cells of plants and green algae. In a process called photosynthesis, light energy is used to produce biochemical energy and the oxygen we breathe. Thus, photosynthesis is one of the most important biological processes on the planet. A central part of photosynthesi ... more

Avita Medical Announces Issuance of a New U.S. Patent for ReCell

Avita Medical Ltd. announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 9,029,140. The patent is directed to methods of making and using an epithelial cell suspension, part of the Company’s novel autologous skin regeneration therapy platform (ReCel ... more

All news on biotechnology

New test could identify resistant tuberculosis faster

The time needed to genetically sequence the bacteria causing tuberculosis (Mtb) from patient samples has been reduced from weeks to days using a new technique developed by a UCL-led team. This could help health service providers to better treat disease, control transmission of this infectio ... more

Detecting lung cancer at an early stage

A new diagnostic method, namely spectral histopathology, facilitates marker-free detection of individual subtypes of lung cancers. It was developed by researchers at the PURE consortium at Ruhr-Universität Bochum (RUB). They have successfully applied it in collaboration with clinicians at t ... more

DNA blood test detects lung cancer mutations

Cancer DNA circulating in the bloodstream of lung cancer patients can provide doctors with vital mutation information that can help optimise treatment when tumour tissue is not available, an international group of researchers has reported at the European Lung Cancer Conference (ELCC) in Gen ... more

Aseptika Granted United States Patent for Biomarkers for Respiratory Infection Onset

Aseptika Limited announced that it has been granted a patent in the United States (US) protecting its invention for a test for respiratory infections, designed to be used by patients at home and by clinicians at the bedside of patients in hospitals. This will open up opportunities for the C ... more

Roche strengthens oncology translational research pipeline by acquiring CAPP Medical

Roche announced it has acquired CAPP Medical, a genomics research company founded by Stanford University oncologists and industry veterans, to advance the development of technology for cancer screening and monitoring through the detection of circulating tumor DNA (ctDNA) in blood.  CAPP Med ... more

Bio-marker set forms the basis for new blood test to detect colorectal cancer

Colorectal cancer is the third most common form of cancer globally and the second most common cause of cancer deaths. The chance of a cure is high if the cancer is detected early enough, but early detection is not a given. Researchers from VIB and KU Leuven - together with various European ... more

Philips enters into collaboration with Janssen to develop new handheld blood test

Royal Philips announced that it has entered into a multi-year development agreement with Janssen Pharmaceutica N.V.. The collaboration aims to develop a new handheld blood test to provide doctors with a novel tool to improve the care of patients with neuropsychiatric disorders.The collabora ... more

analytica Vietnam 2015 more international than ever

This year's analytica Vietnam will have approximately 100 exhibitors from 15 countries, making it more international than ever. As part of the extensive program of related events, feature several international experts will pass on scientific background information about research and trends ... more

MDxHealth's ConfirmMDx Genes Detect Clinically Significant Prostate Cancer

MDxHealth SA announced that data demonstrating the prognostic value of its ConfirmMDx® for Prostate Cancer genes and technology was presented at the ASCO Genitourinary Cancers Symposium 2015.  The data support the ability to predict the presence of clinically significant cancer in biopsy-ne ... more

SkylineDx Appoints Oncologist as Acting as Chief Medical Officer

SkylineDx announced the appointment of Saad Usmani, MD, FACP, as their acting Chief Medical Officer.  Dr. Usmani is currently the Director of Clinical Research (Hematologic Malignancies) and Director of Plasma Cell Disorders at Carolinas HealthCare System’s Levine Cancer Institute in Charlo ... more

All news on diagnostics

SYGNIS signs non-exclusive distribution agreement with Cambridge Bioscience Ltd. for UK and Ireland

SYGNIS AG announced a distribution agreement with Cambridge Bioscience for the commercialization of SYGNIS’ proprietary product portfolio in the UK and Ireland.Under the terms of the agreement, Cambridge Bioscience will promote, market, sell and support TruePrime™ products for primer-free W ... more

Sartorius Starts Off Fiscal 2015 with a Strong First Quarter

Sartorius started off fiscal 2015 with substantial double-digit gains in order intake, sales revenue and earnings. Group order intake rose 13.1%, excluding currency effects; this reported figure surged 22.7%. Sales climbed 17.2% in constant currencies; the reported figure, 27.0%. Operating ... more

Genevac Consolidate Evaporator & Freeze Dryer Operations In Germany

Genevac has announced, as of 1st April 2015, that LMS Consult GmbH (LMS) has been appointed as the exclusive German distributor for its market leading evaporator systems plus the freeze dryer range of its parent company - SP Scientific.For over 30 years - LMS Consulthave successfully sold a ... more

Ximbio Expands Team

Ximbio announced the expansion of its team, with two new appointments. Dr Hugh Spotswood has joined as Senior Business Manager, and Emily Haggerty as a Scientific Portfolio Associate. Hugh’s role as part of Ximbio is to head up the business development function to maximise the revenue creat ... more

INTEGRA Biosciences Opens German Subsidiary

Following on from the successful launch of subsidiaries in France, the UK and the USA - INTEGRA Biosciences has announced the opening in January 2015 of a new organisation based in Konstanz, Germany.Leveraging an existing knowledgeable local sales and service team – INTEGRA Biosciences Deut ... more

TÜV SÜD explains process maturity according to the new ISO 9001

The final version of the revised standard for quality management systems is scheduled for release by the International Organisation for Standardisation (ISO) in autumn 2015. Many organisations have already started to address the expected changes, which are aimed at strengthening the benefit ... more

analytica Vietnam 2015 more international than ever

This year's analytica Vietnam will have approximately 100 exhibitors from 15 countries, making it more international than ever. As part of the extensive program of related events, feature several international experts will pass on scientific background information about research and trends ... more

Sartorius Reviews Fiscal 2014 Results

Sartorius closed fiscal 2014 with significant gains in sales revenue and earnings. At the annual press conference in Goettingen, Germany, CEO Dr. Joachim Kreuzburg stated that the Group had even slightly exceeded its financial targets and reached important milestones: "Our largest division, ... more

Sartorius: Successful Business Year 2014

Sartorius successfully closed fiscal 2014 according to its preliminary figures, and even slightly exceeded its sales revenue and earnings targets. In addition, the Group is set to further sharpen its strategic profile based on the sale of its smallest division, Industrial Technologies, whic ... more

Seward appoints Dan Crothers as Managing Director

Seward Ltd. announced the appointment of Dan Crothers as Managing Director to direct strategy and implement a series of new developments within the Company. Dan, who has worked with Seward since 2008, assumes the new role after success in previous positions, including managing Seward’s Sing ... more

All news on lab technology

Genzyme Receives Innovation Award from the National Organization for Rare Disorders (NORD) for the Development of Cerdelga®

Genzyme, a Sanofi company, announced that it has received the 2015 Industry Innovation Award from the National Organization for Rare Disorders (NORD) in recognition of Cerdelga® (eliglustat) capsules. Genzyme was selected for the company’s work in bringing an additional treatment option to ... more

Intercept Pharmaceuticals Announces Pivotal Phase 3 Clinical Trial of Obeticholic Acid in NASH

Intercept Pharmaceuticals, Inc. announced its plans for an international Phase 3 trial of obeticholic acid (OCA), the company's lead FXR agonist, in patients with non-cirrhotic nonalcoholic steatohepatitis (NASH) with liver fibrosis. OCA has received breakthrough therapy designation in this ... more

Baxter BioScience to Expand Global Oncology Footprint with Acquisition of Oncaspa Portfolio for Leukemia

Baxter International Inc. announced it has signed a definitive agreement to acquire the Oncaspar® (pegaspargase) product portfolio from Sigma-Tau Finanziaria S.p.A. The acquisition further accelerates the innovation capabilities and the commercial presence of Baxter BioScience in growing on ... more

Proteros Achieves Key Milestone in Janssen Lead Discovery Collaboration

Proteros biostructures GmbH announced it had achieved an important milestone in a lead discovery collaboration with Janssen Pharmaceutica NV triggering an undisclosed payment to Proteros.Proteros has collaborated with Janssen for over a decade supporting numerous projects across all therape ... more

Genzyme to collaborate with Ablynx on MS research project

Ablynx announced that it has entered into an exclusive research collaboration with Genzyme, a Sanofi company, to investigate Nanobodies® against a target that plays an important role in multiple sclerosis (MS) and specifically aligns with Genzyme's early-stage MS research programs involving ... more

Horizon Discovery Group plc appoints Mr Grahame Cook as a Non-Executive Director

Horizon Discovery Group plc announced the appointment of Mr Grahame Cook as a Non-Executive Director of the Board with immediate effect. Grahame has also been appointed to the Audit Committee, within which he will assume the role of Chairman. Grahame Cook is an experienced FTSE and AIM non- ... more

Medigene announces milestone payment in phase I/II trial with dendritic cell (DC) vaccines for AML

Medigene AG has announced that the progress achieved in its recently initiated clinical phase I/II trial with dendritic cell (DC) vaccines for the treatment of acute myeloid leukaemia (AML) gives rise to a milestone payment amounting to EUR 700,000 to former contributing shareholders of Med ... more

Merck Receives FDA Fast Track Designation for Evofosfamide

Merck announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the development of evofosfamide (previously known as TH-302), administered in combination with gemcitabine, for the treatment of previously untreated patients with metastatic or locally a ... more

Dyax Corp. Appoints Dr. Abbie Celniker to Board of Directors

Dyax Corp.  announced the appointment of Abbie Celniker, Ph.D., to its Board of Directors.Dr. Celniker currently serves as the President and Chief Executive Officer of Eleven Biotherapeutics, where she also serves on its Board of Directors. Prior to joining Eleven Biotherapeutics, she serve ... more

Pfizer Secures Option to Acquire AM-Pharma

AM-Pharma B.V., and Pfizer Inc. announced that Pfizer has acquired a minority equity interest in AM-Pharma and secured an exclusive option to acquire the remaining equity in the company. The option becomes exercisable upon completion of a Phase II trial of recAP in the treatment of Acute Ki ... more

All news on pharma

UAlberta creates DNA bank to unlock genetic clues about stuttering

Scientists at the University of Alberta's Institute for Stuttering Treatment and Research (ISTAR) want Albertans to give a spit - five millilitres to be precise - to help find the cause and a cure for stuttering.Scientists at the University of Alberta's Institute for Stuttering Treatment an ... more

Novel insights in MET-proto-oncogene might lead to optimizing cancer treatment

The MET-proto-oncogene is involved in the pathogenesis of several tumors and therefore represents an interesting target for future therapies currently tested in dozens of clinical trials. Veronica Finisguerra, Andrea Casazza, Max Mazzone and colleagues from VIB, KU Leuven and UZ Leuven now ... more

'Hydrogels' boost ability of stem cells to restore eyesight and heal brains

Toronto scientists and engineers have made a breakthrough in cell transplantation using a gel-like biomaterial that keeps cells alive and helps them integrate better into tissue. In two early lab trials, this has already shown to partially reverse blindness and help the brain recover from s ... more

Educating the immune system to prevent allergies

With the arrival of spring, millions of Canadians have begun their annual ritual of sneezing and wheezing due to seasonal allergies. A research team at the Montreal Children’s Hospital from the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal is bringing them ... more

Sights set on innovation: New approaches to vision with microchips holds out prospects for the blind

To date, chip-based retinal implants have only permitted a rudimentary restoration of vision. However, modifying the electrical signals emitted by the implants could change that. This is the conclusion of the initial published findings of a project sponsored by the Austrian Science Fund FWF ... more

Engineering bacteria to design vaccines

The EU-funded MycoSynVac project combines gene engineering and biotechnology to design a novel veterinary vaccine chassis based on the bacterium Mycoplasma pneumoniae. By combining their systems biology expertise with cutting-edge synthetic biology methodologies, researchers will engineer ... more

Light in sight

Scientists from the Universities of Bern in Switzerland and Göttingen in Germany have succeeded in restoring vision to blind mice. They've developed a molecular light switch as a potential therapy for acquired blindness. Hereditary blindness caused by a progressive degeneration of the light ... more

Cotton fibres instead of carbon nanotubes

Plant-based cellulose nanofibres do not pose a short-term health risk, especially short fibres, shows a study conducted in the context of National Research Programme "Opportunities and Risks of Nanomaterials" (NRP 64). But lung cells are less efficient in eliminating longer fibres. Similar ... more

NIMH funds major schizophrenia project

Researchers at the University of Virginia School of Medicine will seek to identify the genetic causes of schizophrenia as part of a major project funded by the National Institute of Mental Health to better understand how genetic variation in brain cells affects human health and disease.Mike ... more

Lucideon and partners awarded €3,9m grant to train Industry PhD researchers to develop antibacterial medical materials

Lucideon together with 9 European consortium partners, has been awarded €3.9m (£2.8m) grant by the European Commission to train industry PhD researchers for the development of drug-free antibacterial materials used for medical applications, such as wound care and implants.Biomedical polymer ... more

All news on healthcare
News by department
News according to country
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE